Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) had its price target boosted by equities researchers at Stifel Nicolaus from $105.00 to $109.00.Stifel Nicolaus currently has a rating of Buy on the stock. A number of other analysts have issued reports on the …

Analysts at Raymond James Financial Inc. initiated coverage on Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) stock, starting the company at Market Perform. As a means of comparison, a number of other analysts have commented on the company recently, and the company …